TIAPRIDAL

This brand name is authorized in Germany, France, Lithuania, Poland, Romania, Tunisia

Active ingredients

The drug TIAPRIDAL contains one active pharmaceutical ingredient (API):

1 Tiapride UNII 25N106WEDO - TIAPRIDE HYDROCHLORIDE

Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine). Read about Tiapride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AL03	Tiapride	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides
Discover more medicines within N05AL03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00356843, 00673124, 00673130
Country: FR	Base de données publique des médicaments	Identifier(s): 67890598, 68632565, 68673220
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003179, 1003180, 1059789
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100098941, 100292844, 100316036, 100324998, 100335795, 100349685, 100353600, 100366235, 100384546, 100395047, 100410829, 100422063, 100422123, 100429289, 100468528
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63530001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6483141, 6483142